Vecuronium

From WikiAnesthesia
Revision as of 08:12, 3 January 2023 by Cornel Chiu (talk | contribs) (Brief summary, Uses, contraindication, precautions, pharmacodynamics, adverse effects, chemistry and formulation)
Vecuronium
Vecuronium.svg
Clinical data
Drug class

Neuromuscular blocker

Routes of administration

Intravenous

Dosage
Pharmacodynamics
Mechanism of action

Nicotinic acetylcholine antagonism

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Vecuronium is an steroidal intermediate acting non-depolarizing neuromuscular blocking agent

Uses

  • Optimizing tracheal intubation condition
    • Abduction of vocal cords
    • Opening of mouth
    • Reduction in coughing and gagging
  • Provide surgical relaxation
  • Optimizing mechanical ventilation conditions
    • Reduction in bucking/coughing
    • Reduction in breath stacking
  • Provide paralysis in patients with acute respiratory distress syndrome in the intensive care unit via continuous infusion early in the course of ARDS for patients with a PaO2/FiO2 less than 150. The proposed mechanism of the beneficial effect is possibly by lowering trans-pulmonary pressure reducing barotrauma.

Contraindications

Absolute contraindications

Known hypersensitivity

Precautions

Prolonged duration of action in patients with cholestasis or cirrhosis

Dose requirement can be unpredictable in patients with renal failure

Pharmacology

Pharmacodynamics

Primarily eliminated via hepatic metabolism: 30-40%

Elimination via bile: 40%

Elimination via renal: 20-30%

3-desacetylvecuronium, 17-desacetylvecuronium and 3,17-desacetylvecuronium metabolites have neuromuscular blocking activity

Mechanism of action

Competitive antagonism of acetylcholine at the post junctional receptors preventing depolarization of the muscle preventing any movement. Only one molecule of the neuromuscular blocker is needed to prevent activation of the receptor as it competes with acetylcholine at the two binding sites.

Adverse effects

  • Anaphylactic reaction

Pharmacokinetics

Duration of action of 40 minutes

Chemistry and formulation

2-desmethyl derivative of pancuronium

History

First non-depolarizing neuromuscular blocking agent with an intermediate duration of action to be introduced into clinical practice

References